Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Schneider Electric
Acquired Company
PTC Therapeutics
Paris
South PlainfieldManufacturingEnergymachineryBiotechnologyDescription
Schneider Electric has completed an all-cash acquisition of PTC for $22.6 billion, bringing together expertise in industrial software. This merger aims to create a powerful software and AI platform to optimize industrial processes and enhance customer value. The acquisition is seen as a significant step in leading the future of energy and industrial intelligence. Both companies expect to leverage their strengths to accelerate innovation and offer enhanced solutions globally.
Fundz sees it the moment Schneider Electric makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired PTC Therapeutics?
PTC Therapeutics was acquired by Schneider Electric, based in Paris. The deal was reported on October 9, 2026. Schneider Electric is a global leader in digital transformation of energy management and automation. They are dedicated to making energy safe, reliable, efficient, and sustainable. Schneider Electric is privately held and operates in Manufacturing.
When did Schneider Electric acquire PTC Therapeutics?
Schneider Electric's acquisition of PTC Therapeutics was reported on October 9, 2026. Schneider Electric has completed an all-cash acquisition of PTC for $22.6 billion, bringing together expertise in industrial software. This merger aims to create a powerful software and AI platform to optimize industrial processes and enhance customer value. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does PTC Therapeutics do?
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. It is publicly traded (PTCT), operating in Biotechnology, and is based in South Plainfield.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.